483
Xellia Pharmaceuticals USA LLCXellia Pharmaceuticals USA LLC – FDA 483, Sep 29, 2023
Record Details
Xellia Pharmaceuticals USA LLC in Bedford, OH, a manufacturer of sterile drug products, received a Form 483 with two observations. The inspection revealed significant deficiencies in aseptic process validation, including unrepresentative media fills and inadequate smoke studies for Vancomycin production. Additionally, the firm failed to conduct thorough investigations into unexplained discrepancies, such as the source of a metal shard found in a Vancomycin batch.
View Company Profile
ID · 93d44f5f-72c1-46b2-a9d2-b59938687b28
Other documents for Xellia Pharmaceuticals USA LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.